Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.
about
Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease modelsDevelopment of Taiwan's strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerationsAdvanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug DeliveryEnhanced local bioavailability of single or compound drugs delivery to the inner ear through application of PLGA nanoparticles via round window administration.Nanoparticle-cored dendrimers: functional hybrid nanocomposites as a new platform for drug delivery systems.Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors.Potential Use of Alginate-Based Carriers As Antifungal Delivery SystemNanoscale isoindigo-carriers: self-assembly and tunable properties.Crosstalk of Nanosystems Induced Extracellular Vesicles as Promising Tools in Biomedical Applications.Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed.A novel nanomissile targeting two biomarkers and accurately bombing CTCs with doxorubicin.An NAD(P)H:quinone oxidoreductase 1 (NQO1) enzyme responsive nanocarrier based on mesoporous silica nanoparticles for tumor targeted drug delivery in vitro and in vivo.Nano based drug delivery systems: recent developments and future prospectsNanotechnology for Neuroscience: Promising Approaches for Diagnostics, Therapeutics and Brain Activity Mapping.
P2860
Q26775886-2BA139B9-87AF-4864-9C55-AFFB5BD7A082Q27687656-0ADE5F78-7941-4A0B-9B33-0F6324C27A13Q28076132-C4FA27A9-A52F-428A-A416-A74A1FF7D72FQ34637830-744C6A47-3599-4815-8260-011984B9FE37Q38310576-DA707D08-3AE2-433A-AE1F-163EA0473A78Q38577297-20547FBE-C363-4429-9866-396F9DEFD5F0Q38981743-11ADA10F-28E8-4CAD-9159-D149722DA218Q39134282-6B172095-292E-4F13-A463-9D9746A42764Q41761484-5FD027AB-ABE4-4F47-B8E0-16DCE1D48572Q47359221-623955E3-4BFA-4AD6-BB99-2737087B6112Q48155889-3A314F40-04F5-4C40-8076-423481E0019DQ50656099-654EFB05-13B9-456C-B172-0109D18E7212Q51301248-0B3750BE-C546-496A-A214-E18317BBF53BQ57154808-B956AF3F-F3EE-4573-88A6-3CAFF838F447Q57341436-0B4EFFDB-9D61-4E32-9FF5-E0428DC6DBA9
P2860
Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Innovative pharmaceutical deve ...... anoscale delivery formulation.
@en
Innovative pharmaceutical deve ...... anoscale delivery formulation.
@nl
type
label
Innovative pharmaceutical deve ...... anoscale delivery formulation.
@en
Innovative pharmaceutical deve ...... anoscale delivery formulation.
@nl
prefLabel
Innovative pharmaceutical deve ...... anoscale delivery formulation.
@en
Innovative pharmaceutical deve ...... anoscale delivery formulation.
@nl
P2093
P2860
P356
P1433
P1476
Innovative pharmaceutical deve ...... anoscale delivery formulation.
@en
P2093
Anbu Mozhi
Anil Kumar
Paul C Wang
Xiaoning Zhang
Xing-Jie Liang
Yuanyuan Zhao
P2860
P304
P356
10.1039/C3NR01525D
P407
P577
2013-09-01T00:00:00Z